佐剂
寡核苷酸
核酸
细胞毒性T细胞
抗原
接种疫苗
病毒学
效力
癌症研究
生物
免疫学
癌症
化学
DNA
体外
生物化学
遗传学
作者
Jeongmin Hwang,Jasper W. Dittmar,Janice Kang,Tania Ocampo Ocampo,Michael Evangelopoulos,Zhenyu Han,Sergej Kudruk,Jochen H. Lorch,Chad A. Mirkin
出处
期刊:Nano Letters
[American Chemical Society]
日期:2024-06-14
卷期号:24 (25): 7629-7636
被引量:1
标识
DOI:10.1021/acs.nanolett.4c01392
摘要
Vaccination for cancers arising from human papillomavirus (HPV) infection holds immense potential, yet clinical success has been elusive. Herein, we describe vaccination studies involving spherical nucleic acids (SNAs) incorporating a CpG adjuvant and a peptide antigen (E711–19) from the HPV-E7 oncoprotein. Administering the vaccine to humanized mice induced immunity-dependent on the oligonucleotide anchor chemistry (cholesterol vs (C12)9). SNAs containing a (C12)9-anchor enhanced IFN-γ production >200-fold, doubled memory CD8+ T-cell formation, and delivered more than twice the amount of oligonucleotide to lymph nodes in vivo compared to a simple admixture. Importantly, the analogous construct with a weaker cholesterol anchor performed similar to admix. Moreover, (C12)9-SNAs activated 50% more dendritic cells and generated T-cells cytotoxic toward an HPV+ cancer cell line, UM-SCC-104, with near 2-fold greater efficiency. These observations highlight the pivotal role of structural design, and specifically oligonucleotide anchoring strength (which correlates with overall construct stability), in developing efficacious therapeutic vaccines.
科研通智能强力驱动
Strongly Powered by AbleSci AI